IRINOTECAN ALPHAPHARM irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

irinotecan alphapharm irinotecan hydrochloride trihydrate 40 mg/2 ml concentrated injection vial

alphapharm pty ltd - irinotecan hydrochloride trihydrate -

IRINOTECAN ALPHAPHARM irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

irinotecan alphapharm irinotecan hydrochloride trihydrate 100 mg/5 ml concentrated injection vial

alphapharm pty ltd - irinotecan hydrochloride trihydrate -

Irinotecan Kabi Concentrate for Soln for Inf 100mg/5ml Malta - English - Medicines Authority

irinotecan kabi concentrate for soln for inf 100mg/5ml

fresenius kabi oncology plc - irinotecan - concentrate for solution for infusion - irinotecan 20 mg - antineoplastic agents

Irinotecan Kabi Concentrate for Soln for Inf 300mg/15ml Malta - English - Medicines Authority

irinotecan kabi concentrate for soln for inf 300mg/15ml

fresenius kabi oncology plc - irinotecan - concentrate for solution for infusion - irinotecan 20 mg - antineoplastic agents

Irinotecan Kabi Concentrate for Soln for Inf 500mg/25ml Malta - English - Medicines Authority

irinotecan kabi concentrate for soln for inf 500mg/25ml

fresenius kabi oncology plc - irinotecan - concentrate for solution for infusion - irinotecan 20 mg - antineoplastic agents

IRINOTECAN BAXTER irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

irinotecan baxter irinotecan hydrochloride trihydrate 100 mg/5 ml concentrated injection vial

baxter healthcare pty ltd - irinotecan hydrochloride trihydrate, quantity: 100 mg - injection, concentrated - excipient ingredients: sodium hydroxide; lactic acid; water for injections; hydrochloric acid; sorbitol - irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

IRINOTECAN BAXTER irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

irinotecan baxter irinotecan hydrochloride trihydrate 40 mg/2 ml concentrated injection vial

baxter healthcare pty ltd - irinotecan hydrochloride trihydrate, quantity: 40 mg - injection, concentrated - excipient ingredients: water for injections; lactic acid; sorbitol; hydrochloric acid; sodium hydroxide - irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

IRINOTECAN BAXTER irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

irinotecan baxter irinotecan hydrochloride trihydrate 300 mg/15 ml concentrated injection vial

baxter healthcare pty ltd - irinotecan hydrochloride trihydrate, quantity: 300 mg - injection, concentrated - excipient ingredients: lactic acid; sorbitol; hydrochloric acid; sodium hydroxide; water for injections - irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Irinotecan Ebewe - (2ml vial) Concentrate for Soln for Inf 20mg/ml Malta - English - Medicines Authority

irinotecan ebewe - (2ml vial) concentrate for soln for inf 20mg/ml

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - irinotecan - concentrate for solution for infusion - irinotecan 17.33 mg - antineoplastic agents

Irinotecan Ebewe - (5ml vial) Concentrate for Soln for Inf 20mg/ml Malta - English - Medicines Authority

irinotecan ebewe - (5ml vial) concentrate for soln for inf 20mg/ml

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - irinotecan - concentrate for solution for infusion - irinotecan 17.33 mg - antineoplastic agents